New Hormone-Free drug for hot flashes tested in real life
NCT ID NCT07490431
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study follows 1,500 women in the U.S. who are starting elinzanetant, a new hormone-free medicine for hot flashes and night sweats during menopause. Researchers will track how well it works, how safe it is, and how it affects sleep and quality of life using phone surveys and optional smart rings. The goal is to see if the benefits seen in earlier studies hold up in real-world, everyday care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
elinzanetant
What this could lead to
If successful, this study could confirm that elinzanetant works well in everyday life to reduce hot flashes and improve sleep for menopausal women.
What could go wrong
This is an observational study, not a controlled trial, so results may be less reliable. It only includes women already prescribed the drug, and long-term effects are not fully known.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOMOTOR SYMPTOMS (VMS) ASSOCIATED WITH MENOPAUSE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayer
Whippany, New Jersey, 07981, United States